What is the 13F Pro Quality Score for MGTX?

13F Pro ranks MeiraGTx Holdings plc (MGTX) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View MGTX's current score at https://13fpro.ai/research/MGTX (free sign-up required for the full ranking).

Which hedge funds own the most MGTX stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of MGTX include Sanofi, PERCEPTIVE ADVISORS, Rubric Capital Management. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/MGTX as soon as new 13F filings post.

Where does 13F Pro source MGTX data?

All MeiraGTx Holdings plc fundamentals and ownership data come directly from SEC EDGAR. MeiraGTx Holdings plc files with the SEC under CIK 1735438. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is MGTX in?

MeiraGTx Holdings plc (MGTX) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is MGTX research updated on 13F Pro?

MGTX's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

MeiraGTx Holdings plc(MGTX)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1735438 MGTX stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

MGTX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for MeiraGTx Holdings plc (MGTX), a Healthcare sector company. MGTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), MeiraGTx Holdings plc reports quarterly revenue of $293.0K, net income of $-46.3M, free cash flow of $15.8M. Top institutional holders of MGTX by reported 13-F value include Sanofi, PERCEPTIVE ADVISORS, Rubric Capital Management, based on the most recent SEC filings. MGTX trades on the Nasdaq exchange and files with the SEC under CIK 1735438. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MGTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MeiraGTx Holdings plc directly from SEC EDGAR.

Revenue

Q1 2026

$293.0K

Net Income

Q1 2026

$-46.3M

Free Cash Flow

Q1 2026

$15.8M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+144.6% YoY

$81.4MFY 2025

FY21 $37.7MFY23 $14.0MFY24 $33.3MFY25 $81.4M

Net Income

+22.7% YoY

$-114.2MFY 2025

FY21 $-79.6MFY23 $-84.0MFY24 $-147.8MFY25 $-114.2M

Operating Income

+35.5% YoY

$-106.0MFY 2025

FY21 $-72.8MFY23 $-137.1MFY24 $-164.2MFY25 $-106.0M

EPS (Diluted)

+33.0% YoY

$-1.42FY 2025

FY21 $-1.80FY23 $-1.49FY24 $-2.12FY25 $-1.42

Total Assets

-9.4% YoY

$244.4MFY 2025

FY21 $320.2MFY23 $326.7MFY24 $269.8MFY25 $244.4M

Op. Cash Flow

+55.6% YoY

$-46.4MFY 2025

FY21 $-10.5MFY23 $-105.4MFY24 $-104.5MFY25 $-46.4M

Metric	FY 2025	FY 2024	FY 2023	FY 2021	FY 2018	FY 2017
Revenue	$81.4M +144.6%	$33.3M +137.4%	$14.0M -62.8%	$37.7M	—	—
Net Income	$-114.2M +22.7%	$-147.8M -75.9%	$-84.0M -5.6%	$-79.6M +4.0%	$-82.9M -166.9%	$-31.0M
Operating Income	$-106.0M +35.5%	$-164.2M -19.8%	$-137.1M -88.4%	$-72.8M +6.8%	$-78.1M -146.5%	$-31.7M
EPS (Diluted)	$-1.42 +33.0%	$-2.12 -42.3%	$-1.49 +17.2%	$-1.80	—	—
Total Assets	$244.4M -9.4%	$269.8M -17.4%	$326.7M +2.1%	$320.2M +230.4%	$96.9M +274.8%	$25.9M
Operating Cash Flow	$-46.4M +55.6%	$-104.5M +0.8%	$-105.4M -900.6%	$-10.5M +82.1%	$-58.9M -226.2%	$-18.1M

AI Insight: MGTX Financial Trends

MeiraGTx flipped to profitability in Q4 2025 on $75M revenue spike, but collapsed back to losses in Q1 2026 with zero revenue.

• Q4 2025 delivered $75M revenue, $15M net income, and $47M operating cash flow—first profitable quarter on record.

• Operating margin swung from –62% in Q3 2025 to +35% in Q4 2025, driven by revenue recognition and operating leverage.

• Equity deteriorated from $80M (Q2 2024) to –$58M (Q1 2026), signaling cumulative losses eroded shareholder value.

⚠ Q1 2026 revenue collapsed to $0M and net loss resumed at –$46M; Q4 2025 profit appears non-recurring or one-time.

⚠ Negative equity of –$58M in Q1 2026 indicates liabilities exceed assets; company is technically insolvent on book value.

AI Insight: MGTX Ratio Trends

Q4 2025 showed a dramatic turnaround to profitability with 35.1% operating margin and 20.0% net profit margin, but Q1 2026 regression to -75.7% ROA signals the gains were likely non-recurring.

• Q4 2025 swung to 35.1% operating margin and 20.0% NPM from deeply negative prior quarters, with ROA recovering to 24.7%.

• Q1 2026 ROA plummeted to -75.7%, the worst since Q2 2025 (-78.1%), erasing Q4 2025 gains and signaling a one-quarter anomaly.

⚠ Sustainability of Q4 2025 profitability is in serious doubt; ROA has returned to loss-making territory in Q1 2026.

⚠ Majority of reported metrics (ROE, ROIC, D/E) remain absent, limiting visibility into capital structure and asset efficiency trends.

Get alerted when MGTX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MeiraGTx Holdings plc including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of MGTX

Sanofi
$105.6M12,197,737 sh
PERCEPTIVE ADVISORS LLC
$89.3M10,326,103 sh
Rubric Capital Management LP
$60.6M7,000,000 sh
JOHNSON & JOHNSON
$57.5M6,641,064 sh
ADAGE CAPITAL PARTNERS GP, L.L.C.
$34.6M4,000,000 sh
MILLENNIUM MANAGEMENT LLC
$30.0M3,465,699 sh
BlackRock, Inc.
$27.4M3,168,148 sh
Prosight Management, LP
$22.8M2,629,971 sh
683 Capital Management, LLC
$21.2M2,450,000 sh
Opaleye Management Inc.
$18.4M2,123,259 sh

Fund	Value	Shares
Sanofi	$105.6M	12,197,737
PERCEPTIVE ADVISORS LLC	$89.3M	10,326,103
Rubric Capital Management LP	$60.6M	7,000,000
JOHNSON & JOHNSON	$57.5M	6,641,064
ADAGE CAPITAL PARTNERS GP, L.L.C.	$34.6M	4,000,000
MILLENNIUM MANAGEMENT LLC	$30.0M	3,465,699
BlackRock, Inc.	$27.4M	3,168,148
Prosight Management, LP	$22.8M	2,629,971
683 Capital Management, LLC	$21.2M	2,450,000
Opaleye Management Inc.	$18.4M	2,123,259

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put MGTX on your watchlist

Track score changes the day MeiraGTx Holdings plc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is MGTX a good stock to buy?

13F Pro's AI-powered analysis of MeiraGTx Holdings plc (MGTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MGTX are available on the MGTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MGTX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MGTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MeiraGTx Holdings plc's investment landscape.